India has reportedly exempted some companies from South Korea and the US from the mandatory 100 percent physical checks that have been imposed on Chinese-origin imports into the country. Similar relaxations may also be extended to manufacturers heavily dependent on imports, after the move affected supply.
As of now, imports from China, Hong Kong and Macau are subjected to 100 percent physical checks by the customs department at all entry points such as ports and airports. India’s move came after Indian and Chinese troops clashed along the Line of Actual Control (LAC) in Ladakh.
"Some changes have been made to release the consignments of select companies. Shipments of HP, Dell, Samsung and Apple have been cleared following the relaxation. This could also be brought in for manufacturer-importers,” a source told The Economic Times.
Moneycontrol could not independently verify the report.
A government official said the goal is to reduce India’s reliance on imports from “single sources” and prepare for an “eventuality like COVID-19 that hampered supplies.”
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
The relaxation likely came after intervention from industry bodies such as the Confederation of Indian Industry (CII), the US-India Strategic Partnership Forum and the US-India Business Council alerted the Centre to supply chain disruptions due to delay of consignments.
Besides bodies, the small and medium enterprises (SME) ministry, and department for industrial policy and internal trade had also taken up the matter with the finance ministry.India had said the move was triggered by alerts related to narcotics, but the industry said the checks were targeting goods inbound from China.